SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-030502
Filing Date
2023-11-07
Accepted
2023-11-07 09:19:44
Documents
65
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sava20230930_10q.htm   iXBRL 10-Q 852349
2 EXHIBIT 31.1 ex_566477.htm EX-31.1 14272
3 EXHIBIT 31.2 ex_566478.htm EX-31.2 13877
4 EXHIBIT 32.1 ex_566479.htm EX-32.1 7785
10 a1.jpg GRAPHIC 60544
11 a03.jpg GRAPHIC 49207
12 a04.jpg GRAPHIC 44466
13 cass01.jpg GRAPHIC 16219
14 cass02.jpg GRAPHIC 20578
15 chart_2.jpg GRAPHIC 71417
  Complete submission text file 0001437749-23-030502.txt   4697010

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA sava-20230930.xsd EX-101.SCH 39981
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sava-20230930_cal.xml EX-101.CAL 29973
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sava-20230930_def.xml EX-101.DEF 264484
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE sava-20230930_lab.xml EX-101.LAB 224894
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sava-20230930_pre.xml EX-101.PRE 287483
59 EXTRACTED XBRL INSTANCE DOCUMENT sava20230930_10q_htm.xml XML 517472
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29959 | Film No.: 231382027
SIC: 2834 Pharmaceutical Preparations